Canada markets close in 4 hours 52 minutes

Ocuphire Pharma, Inc. (OCUP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.71000.0000 (0.00%)
As of 11:04AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 44.33M
Enterprise Value -2.84M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.02
Price/Book (mrq)0.96
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.55

Trading Information

Stock Price History

Beta (5Y Monthly) 0.34
52-Week Change 3-56.04%
S&P500 52-Week Change 325.26%
52 Week High 34.5800
52 Week Low 31.5000
50-Day Moving Average 31.8218
200-Day Moving Average 32.7850

Share Statistics

Avg Vol (3 month) 3224.58k
Avg Vol (10 day) 3153.06k
Shares Outstanding 525.92M
Implied Shares Outstanding 626.83M
Float 823.37M
% Held by Insiders 16.51%
% Held by Institutions 113.15%
Shares Short (Apr 30, 2024) 41.22M
Short Ratio (Apr 30, 2024) 44.79
Short % of Float (Apr 30, 2024) 45.04%
Short % of Shares Outstanding (Apr 30, 2024) 44.77%
Shares Short (prior month Mar 28, 2024) 41.57M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 06, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Nov 06, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -52.42%
Operating Margin (ttm)-321.05%

Management Effectiveness

Return on Assets (ttm)-12.83%
Return on Equity (ttm)-20.77%

Income Statement

Revenue (ttm)19.05M
Revenue Per Share (ttm)0.88
Quarterly Revenue Growth (yoy)-95.80%
Gross Profit (ttm)N/A
EBITDA -10.56M
Net Income Avi to Common (ttm)-9.99M
Diluted EPS (ttm)-0.4600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)50.52M
Total Cash Per Share (mrq)2.04
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)13.35
Book Value Per Share (mrq)2.08

Cash Flow Statement

Operating Cash Flow (ttm)-1.11M
Levered Free Cash Flow (ttm)244.12k